ASMBS: Bariatric Surgery Found Superior to Drugs in Controlling Diabetes

Washington, D.C.

For morbidly obese patients with type 2 diabetes, bariatric surgery led to more improvement in glycosylated hemoglobin than standard treatment, a retrospective analysis showed.

Those who underwent Roux-en-Y gastric bypass had an average drop in hemoglobin A1c of 21% within a year (P<0.001), compared with an increase of 11% with conventional treatment (P<0.05), which included oral hypoglycemics and insulin, according to Daniel Mumme, M.D., of Gundersen Lutheran Medical Center in La Crosse, Wis.

Body mass indices fell from an average of 47.3 to 30.9 kg/m2 (P<0.05) in the surgery group and did not change significantly from 44.9 kg/m2 in the conventional-treatment group, he reported at the American Society for Metabolic & Bariatric Surgery meeting here. More >>

 Subscribe to Gastric Bypass Surgery News